Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Patria Investments
PAX
$1.78B
| $1.5M | ﹤0.01% |
106,535
+43,751
| +70% | +$525K |
2023 Q2
8 quarters
|
|
3027
QuantumScape Corp
QS
$2.79B
| $1.5M | ﹤0.01% |
222,474
+67,514
| +44% | +$285K |
2022 Q1
13 quarters
|
|
3028
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $1.49M | ﹤0.01% |
18,761
| – | – |
2022 Q1
13 quarters
|
|
3029
Insteel Industries
IIIN
$561M
| $1.48M | ﹤0.01% |
39,773
+15,262
| +62% | +$509K |
2016 Q1
37 quarters
|
|
3030
CALL
Levi Strauss
LEVI
$7.69B
| $1.48M | ﹤0.01% |
+80,000
| New | +$1.33M |
2025 Q2
0 quarters
|
|
3031
Hackett Group
HCKT
$270M
| $1.48M | ﹤0.01% |
58,167
+18,514
| +47% | +$471K |
2013 Q2
48 quarters
|
|
3032
Navitas Semiconductor
NVTS
$3.17B
| $1.48M | ﹤0.01% |
225,729
+67,768
| +43% | +$261K |
2023 Q1
9 quarters
|
|
3033
iShares MSCI Singapore ETF
EWS
$1.43B
| $1.48M | ﹤0.01% |
56,843
+11,900
| +26% | +$294K |
2022 Q1
13 quarters
|
|
|
AGNT
3034
AGNT Inc
AGNT
$622M
| $1.47M | ﹤0.01% |
162,042
+40,312
| +33% | +$352K |
2019 Q1
25 quarters
|
|
3035
SK Telecom
SKM
$14B
| $1.47M | ﹤0.01% |
63,021
-24,640
| -28% | -$531K |
2013 Q2
48 quarters
|
|
3036
HBT Financial
HBT
$1.32B
| $1.47M | ﹤0.01% |
58,359
+5,939
| +11% | +$139K |
2022 Q1
13 quarters
|
|
|
INN
3037
Summit Hotel Properties
INN
$644M
| $1.47M | ﹤0.01% |
288,375
-138,496
| -32% | -$609K |
2013 Q2
48 quarters
|
|
3038
Cable One
CABO
$64.7M
| $1.47M | ﹤0.01% |
10,806
+1,295
| +14% | +$243K |
2015 Q3
39 quarters
|
|
3039
Weibo
WB
$1.57B
| $1.47M | ﹤0.01% |
153,969
-22,807
| -13% | -$200K |
2016 Q1
37 quarters
|
|
|
HPP
3040
Hudson Pacific Properties
HPP
$613M
| $1.46M | ﹤0.01% |
76,320
+24,654
| +48% | +$400K |
2013 Q2
48 quarters
|
|
3041
NB Bancorp
NBBK
$987M
| $1.46M | ﹤0.01% |
81,902
+22,570
| +38% | +$381K |
2024 Q2
4 quarters
|
|
3042
Angi Inc
ANGI
$252M
| $1.46M | ﹤0.01% |
+95,720
| New | +$1.38M |
2025 Q2
0 quarters
|
|
3043
Enliven Therapeutics
ELVN
$3.35B
| $1.46M | ﹤0.01% |
72,784
+22,427
| +45% | +$425K |
2023 Q1
9 quarters
|
|
|
TBPH
3044
DELISTED
Theravance Biopharma
TBPH
| $1.45M | ﹤0.01% |
131,802
+79,769
| +153% | +$776K |
2014 Q2
44 quarters
|
|
|
AIOT
3045
PowerFleet Inc
AIOT
$376M
| $1.45M | ﹤0.01% |
337,071
+113,545
| +51% | +$561K |
2024 Q2
4 quarters
|
|
3046
Hallador Energy
HNRG
$646M
| $1.45M | ﹤0.01% |
91,498
+66,035
| +259% | +$1.02M |
2022 Q4
10 quarters
|
|
3047
Oric Pharmaceuticals
ORIC
$1.25B
| $1.45M | ﹤0.01% |
142,681
+40,891
| +40% | +$275K |
2023 Q2
8 quarters
|
|
|
MTAL
3048
DELISTED
Metals Acquisition
MTAL
| $1.44M | ﹤0.01% |
119,507
+63,646
| +114% | +$658K |
2024 Q1
5 quarters
|
|
|
RYZ
3049
Ryerson Holding Corp
RYZ
$1.38B
| $1.44M | ﹤0.01% |
66,953
+22,058
| +49% | +$476K |
2016 Q3
35 quarters
|
|
|
CDTX
3050
DELISTED
Cidara Therapeutics
CDTX
| $1.44M | ﹤0.01% |
29,624
+29,596
| +105,700% | +$711K |
2025 Q1
1 quarter
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.